200 related articles for article (PubMed ID: 35116580)
21. ETNK2 Low-Expression Predicts Poor Prognosis in Renal Cell Carcinoma with Immunosuppressive Tumor Microenvironment.
Chu J; Qian XX; Zhang XM; Jiang T; Li XJ; Sun W
J Oncol; 2023; 2023():1743357. PubMed ID: 36866238
[TBL] [Abstract][Full Text] [Related]
22. Characterization and verification of MMP family members as potential biomarkers in kidney clear cell renal carcinoma.
Zhao T; Li X; Li M; Jamil M; Zhang J
Am J Cancer Res; 2023; 13(9):3941-3962. PubMed ID: 37818055
[TBL] [Abstract][Full Text] [Related]
23. HOXD1 functions as a novel tumor suppressor in kidney renal clear cell carcinoma.
Cui Y; Zhang C; Li Y; Ma S; Cao W; Guan F
Cell Biol Int; 2021 Jun; 45(6):1246-1259. PubMed ID: 33559901
[TBL] [Abstract][Full Text] [Related]
24. Deciphering key genes involved in cisplatin resistance in kidney renal clear cell carcinoma through a combined
Malik M; Maqbool M; Nisar T; Akhter T; Ujan JA; Algarni AS; Joufi FAA; Alanazi SSK; Almotared MH; Bekhit MMS; Jamil M
Oncol Res; 2023; 31(6):899-916. PubMed ID: 37744271
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic role of basic leucine zipper transcription factor in kidney renal clear cell carcinoma.
Zhang H; Zhang H; Hu Y; Huang B; Chen J; Chen L
Transl Androl Urol; 2022 Feb; 11(2):238-252. PubMed ID: 35280662
[TBL] [Abstract][Full Text] [Related]
26. Multi-omics Analysis of Prognostic Significance and Immune Infiltration of FASTK Family Members in Kidney Renal Clear Cell Carcinoma.
Zhong G; Wu D; Chen H; Yan L; Xiang Q; Liu Y; Wang T
Evol Bioinform Online; 2023; 19():11769343231212078. PubMed ID: 38033663
[TBL] [Abstract][Full Text] [Related]
27. ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.
Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
Front Oncol; 2022; 12():632042. PubMed ID: 35515103
[TBL] [Abstract][Full Text] [Related]
28. A Novel Gene Signature of Tripartite Motif Family for Predicting the Prognosis in Kidney Renal Clear Cell Carcinoma and Its Association With Immune Cell Infiltration.
Zheng D; Zhang Y; Xia Y; Cheng F
Front Oncol; 2022; 12():840410. PubMed ID: 35371994
[TBL] [Abstract][Full Text] [Related]
29. Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.
Song J; Yang R; Wei R; Du Y; He P; Liu X
Mol Med; 2022 May; 28(1):47. PubMed ID: 35508972
[TBL] [Abstract][Full Text] [Related]
30. Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma.
Sun X; Liu P
Front Oncol; 2023; 13():1073941. PubMed ID: 36816967
[TBL] [Abstract][Full Text] [Related]
31. Pseudogene HSPA7 is a poor prognostic biomarker in Kidney Renal Clear Cell Carcinoma (KIRC) and correlated with immune infiltrates.
Ding C; He R; Zhang J; Dong Z; Wu J
Cancer Cell Int; 2021 Aug; 21(1):435. PubMed ID: 34412642
[TBL] [Abstract][Full Text] [Related]
32. The discovery of promising candidate biomarkers in kidney renal clear cell carcinoma: evidence from the in-depth analysis of high-throughput data.
Li X; Li M; Zhao T; Zhang J
Am J Cancer Res; 2023; 13(9):4288-4304. PubMed ID: 37818073
[TBL] [Abstract][Full Text] [Related]
33. KCNN4 is a potential prognostic marker and critical factor affecting the immune status of the tumor microenvironment in kidney renal clear cell carcinoma.
Chen S; Wang C; Su X; Dai X; Li S; Mo Z
Transl Androl Urol; 2021 Jun; 10(6):2454-2470. PubMed ID: 34295732
[TBL] [Abstract][Full Text] [Related]
34. Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis.
Ye Y; Jiang H; Wu Y; Wang G; Huang Y; Sun W; Zhang M
Front Mol Biosci; 2022; 9():1001225. PubMed ID: 36213111
[No Abstract] [Full Text] [Related]
35. Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation.
Zou X; Guo B; Ling Q; Mo Z
Front Mol Biosci; 2022; 9():832238. PubMed ID: 35127830
[No Abstract] [Full Text] [Related]
36. Survival Prognosis, Tumor Immune Landscape, and Immune Responses of PPP1R18 in Kidney Renal Clear Cell Carcinoma and Its Potentially Double Mechanisms.
Wang Y; Liu S; Chen Y; Zhu B; Xing Q
World J Oncol; 2022 Feb; 13(1):27-37. PubMed ID: 35317332
[TBL] [Abstract][Full Text] [Related]
37. Identification and Verification of Tumor Immune Microenvironment-Related Prognostic Genes in Kidney Renal Clear Cell Carcinoma.
Kong G; Wang Y; Huang Y; Shi Z
Biomed Res Int; 2022; 2022():5563668. PubMed ID: 35127943
[TBL] [Abstract][Full Text] [Related]
38. Interaction of RARRES1 with ICAM1 modulates macrophages to suppress the progression of kidney renal clear cell carcinoma.
Geng X; Chi K; Liu C; Fu Z; Wang X; Meng L; Wang H; Cai G; Chen X; Hong Q
Front Immunol; 2022; 13():982045. PubMed ID: 36353618
[TBL] [Abstract][Full Text] [Related]
39. LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma.
Gong Y; Lv Y; Xu F; Xiu Y; Lu Y; Liu Z; Deng L
J Clin Lab Anal; 2022 Sep; 36(9):e24648. PubMed ID: 36082464
[TBL] [Abstract][Full Text] [Related]
40. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]